These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6741742)

  • 1. Exogenous gangliosides enhance recovery from cns injury.
    Karpiak SE
    Adv Exp Med Biol; 1984; 174():489-97. PubMed ID: 6741742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside treatment improves recovery of alternation behavior after unilateral entorhinal cortex lesion.
    Karpiak SE
    Exp Neurol; 1983 Aug; 81(2):330-9. PubMed ID: 6873218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gangliosides accelerate rat neonatal learning and levels of cortical acetylcholinesterases.
    Karpiak SE; Vilim F; Mahadik SP
    Dev Neurosci; 1983-1984; 6(2):127-35. PubMed ID: 6678760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cerebral edema with GM1 ganglioside.
    Karpiak SE; Mahadik SP
    J Neurosci Res; 1984; 12(2-3):485-92. PubMed ID: 6094838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve regeneration in exogenous cerebral ganglioside-treated rats.
    Sebille A
    Muscle Nerve; 1984 May; 7(4):278-80. PubMed ID: 6727911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside-induced enhancement of behavioral recovery after bilateral lesions of the entorhinal cortex.
    Ramirez JJ; Fass B; Kilfoil T; Henschel B; Grones W; Karpiak SE
    Brain Res; 1987 Jun; 414(1):85-90. PubMed ID: 3620925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a unified theory of ganglioside-mediated functional restoration after brain injury: lesion size, not lesion site, is the primary factor determining efficacy.
    Ramirez JJ; Sabel BA
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):415-38. PubMed ID: 2130659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage.
    Sabel BA; Slavin MD; Stein DG
    Science; 1984 Jul; 225(4659):340-2. PubMed ID: 6740316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced recovery of learned alternation in ganglioside-treated rats after unilateral entorhinal lesions.
    Ramirez JJ; Fass-Holmes B; Karpiak SE; Harshbarger R; Zengel D; Wright P; Valbuena M
    Behav Brain Res; 1991 Apr; 43(1):99-101. PubMed ID: 1859620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A
    Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS.
    Fass B; Ramirez JJ
    J Neurosci Res; 1984; 12(2-3):445-58. PubMed ID: 6502760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
    Casamenti F; Milan F; Pepeu G
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.
    Kojima H; Gorio A; Janigro D; Jonsson G
    Neuroscience; 1984 Dec; 13(4):1011-22. PubMed ID: 6441897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gangliosides upon recovery of aspartate/glutamatergic synapses in striatum after lesions of the rat sensorimotor cortex.
    Shifman M
    Brain Res; 1991 Dec; 568(1-2):323-4. PubMed ID: 1814577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some functional consequences of chronic GM1 ganglioside administration in brain damaged rats.
    Stein DG
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):405-13. PubMed ID: 2130658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
    Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
    Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesioning and recovery of the serotoninergic hippocampal afferents: differential effects of GM1 ganglioside.
    Lombardi G; Beni M; Consolazione A; Moroni F
    Neuropharmacology; 1988 Nov; 27(11):1085-8. PubMed ID: 2462696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei.
    Casamenti F; Bracco L; Bartolini L; Pepeu G
    Brain Res; 1985 Jul; 338(1):45-52. PubMed ID: 4027590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve.
    Sautter J; Schwartz M; Duvdevani R; Sabel BA
    Brain Res; 1991 Nov; 565(1):23-33. PubMed ID: 1773355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.